Huff Curtis W's Form 4 filing
Comera Life Sciences Holdings, Inc. (CMRA) · filed Jan 3, 2024
- Accession no.
- 0000950170-24-001385
- Filed
- Jan 3, 2024, 8:09 PM ET
- Trade date
- Dec 29, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 2 derivative transactions. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huff Curtis WCIK 0001250127 | 10% Owner |
| Freebird Partners LPCIK 0001955231 | 10% Owner |
| Freebird Investments LLCCIK 0001971406 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +2,453,636 | $0.055 | +$134,949.98 | 2,453,636 | Direct | |
| Dec 29, 2023 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +4,907,272 | – | – | 7,362,005 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.